Wnt	O
/	O
beta	B-GENE
-	I-GENE
catenin	E-GENE
signaling	O
regulates	O
Yes	B-GENE
-	I-GENE
associated	I-GENE
protein	E-GENE
(	O
YAP	S-GENE
)	O
gene	O
expression	O
in	O
colorectal	O
carcinoma	O
cells	O
.	O


Mutations	O
in	O
the	O
Wnt	O
/	O
beta	B-GENE
-	I-GENE
catenin	E-GENE
pathway	O
occur	O
in	O
most	O
colorectal	O
cancers	O
(	O
CRCs	O
)	O
,	O
and	O
these	O
mutations	O
lead	O
to	O
increased	O
nuclear	O
accumulation	O
of	O
the	O
beta	B-GENE
-	I-GENE
catenin	E-GENE
transcriptional	O
co	O
-	O
activator	O
.	O


In	O
the	O
nucleus	O
,	O
beta	B-GENE
-	I-GENE
catenin	E-GENE
associates	O
with	O
TCF	B-GENE
/	I-GENE
LEF	E-GENE
sequence	O
specific	O
transcription	O
factors	O
to	O
activate	O
target	O
gene	O
expression	O
.	O


The	O
Hippo	O
pathway	O
restricts	O
cellular	O
growth	O
by	O
preventing	O
nuclear	O
accumulation	O
of	O
the	O
Yes	B-GENE
-	I-GENE
associated	I-GENE
protein	E-GENE
(	O
YAP	S-GENE
)	O
transcriptional	O
co	O
-	O
activator	O
.	O
YAP	S-GENE
expression	O
is	O
elevated	O
in	O
CRCs	O
suggesting	O
that	O
,	O
like	O
Wnt	O
/	O
beta	B-GENE
-	I-GENE
catenin	E-GENE
signaling	O
,	O
the	O
Hippo	O
pathway	O
may	O
contribute	O
to	O
colorectal	O
carcinogenesis	O
.	O


Regulation	O
of	O
YAP	S-GENE
at	O
the	O
post	O
-	O
translational	O
level	O
has	O
been	O
well	O
studied	O
but	O
the	O
transcription	O
factors	O
that	O
control	O
YAP	S-GENE
gene	O
expression	O
are	O
unknown	O
.	O


Here	O
we	O
demonstrate	O
that	O
beta	B-GENE
-	I-GENE
catenin	E-GENE
/	O
TCF4	S-GENE
complexes	O
bind	O
a	O
DNA	O
enhancer	O
element	O
within	O
the	O
first	O
intron	O
of	O
the	O
YAP	S-GENE
gene	O
to	O
drive	O
YAP	S-GENE
expression	O
in	O
CRC	O
cells	O
.	O


As	O
such	O
,	O
reducing	O
beta	B-GENE
-	I-GENE
catenin	E-GENE
expression	O
in	O
CRC	O
cells	O
using	O
shRNAs	O
leads	O
to	O
decreased	O
YAP	S-GENE
mRNA	O
and	O
protein	O
levels	O
.	O
YAP	S-GENE
is	O
abundantly	O
expressed	O
in	O
the	O
cytoplasm	O
and	O
nuclei	O
of	O
several	O
established	O
human	O
colon	O
cancer	O
cell	O
lines	O
and	O
this	O
localization	O
pattern	O
is	O
insensitive	O
to	O
plating	O
density	O
.	O


Finally	O
,	O
we	O
show	O
that	O
YAP	S-GENE
expression	O
is	O
elevated	O
in	O
the	O
majority	O
of	O
a	O
panel	O
of	O
primary	O
human	O
colorectal	O
tumors	O
compared	O
with	O
its	O
expression	O
in	O
uninvolved	O
colonic	O
mucosa	O
,	O
and	O
that	O
YAP	S-GENE
and	O
beta	B-GENE
-	I-GENE
catenin	E-GENE
localize	O
to	O
the	O
nuclear	O
compartment	O
of	O
tumor	O
cells	O
.	O


Together	O
,	O
these	O
results	O
implicate	O
YAP	S-GENE
as	O
an	O
oncogene	O
whose	O
expression	O
is	O
driven	O
by	O
aberrant	O
Wnt	O
/	O
beta	B-GENE
-	I-GENE
catenin	E-GENE
signaling	O
in	O
human	O
CRC	O
cells	O
.	O
